Influence of plastic surgery for melanoma on progression-free survival in patients with skin melanoma according to the degree of tumor lymphoid infiltration

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of the study was to analyze the effect of plastic methods for closing the defect after excision of primary skin melanoma according to the degree of lymphoid infiltration of the tumor.

Material and methods. Patients with primary skin melanoma (SM) treated in 2013 (n = 337) were studied; these patients were randomized into 2 groups using the method of blind selection to the main (n = 182). In these groups, the tumor removal operation in patients ended with plastic tissue defect and the group comparisons (n = 155) (after removal of the tumor, simple linear wound closure was performed).

Results. It was found that pronounced lymphoid tumor infiltration in patients with primary skin melanoma as a predictor of a favorable prognosis (in terms of the occurrence of locoregional recurrence) is realized in patients with plastic defect replacement significantly 2 times more often than in patients without plastic surgery in the period from 12 to 60 months of observation.

Discussion. The dependence of the occurrence of locoregional relapses in patients on lymphoid infiltration of the tumor and the performance of plastic surgery was revealed. In general, all patients who underwent plastic surgery have an advantage in terms of the occurrence of locoregional relapses in the long term for a period of up to 5 years by 12.5%. In patients with severe lymphoid infiltration and plastic surgery, locoregional relapses occur almost 2 times less often than in patients without plastic surgery, starting from a follow-up period of 12–36 months by 20.6% (22.9% and 43.5%, respectively; p = 0.008), and in the period from 36 to 60 months of observation by 24.7% (25.3% and 50.0%, respectively; p = 0.002).

Conclusion. The use of plastic techniques for closing a wound defect in patients with skin melanoma with pronounced lymphoid tumor infiltration reduces the risk of gross scarring and halves the risk of locoregional metastasis as compared to linear suturing of the postoperative defect.

Full Text

Restricted Access

About the authors

Sergei A. Yargunin

Krasnodar cancer center No.1

Author for correspondence.
Email: sdocer@rambler.ru
ORCID iD: 0000-0001-5252-7179

MD, PhD, the Head of the Department

Russian Federation, Krasnodar

Ya. N. Shoykhet

Altay State Medical University

Email: sdocer@rambler.ru
ORCID iD: 0000-0002-5253-4325
Russian Federation, Barnaul

A. F. Lazarev

Altay State Medical University

Email: sdocer@rambler.ru
ORCID iD: 0000-0003-1080-5294
Russian Federation, Barnaul

References

  1. Burton A.L., Roach B.A., Mays M.P., Chen A.F., Ginter A.R.B., Vierling M.A., et al. Prognostic significance of tumor infiltrating lymphocytes in melanoma // Am Surg. 2011. Vol. 77. N 2. P. 188–192.
  2. Wu R., Forget M.-A., Chacon J., Bernatchez C., Haymaker C., Qing J., et al. Adoptive T-cell Therapy Using Autologous Tumor-infiltrating Lymphocytes for Metastatic Melanoma: Current Status and Future // Cancer J. 2012. Vol. 18. N 2. P. 160–175.
  3. Tan S., Khumalo N., Bayat A. Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies // Front Immunol. 2019. Vol 10. P. 1810. doi: 10.3389/fimmu.2019.01810.
  4. Rutkowski J.M., Moya M., Johannes J., Goldman J., Swartz M.A. Secondary lymphedema in the mouse tail: lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9 // Microvasc Res. 2006. Vol. 72. N 3. P. 161–171. doi: 10.1016/j.mvr.2006.05.009 .
  5. Zampell J.C., Yan A., Elhadad S., Avraham T., Weitman E., Mehrara B.J. CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis // PLoS One. 2012. Vol. 7. N 11. P. e49940.
  6. Das S., Skobe M. Lymphatic vessel activation in cancer // Ann N Y Acad Sci. 2008. N. 1131. P. 235–241.
  7. Southern B.D., Grove L.M., Rahaman S.O., Abraham S., Scheraga R.G., Niese K.A., et al. Matrix-driven myosin II mediates the pro-fibrotic fibroblast phenotype // J Biol Chem. 2016. Vol. 291. N 12. P. 6083–6095. doi: 10.1074/jbc.M115.712380.
  8. Kubow K.E., Vukmirovic R., Zhe L., Klotzsch E., Smith M.L., Gourdon D., et al. Mechanical forces regulate the interactions of fibronectin and collagen I in extracellular matrix. Nat Commun // 2015. N 6. P. 8026. doi: 10.1038/ncomms 9026.
  9. Backs J., Song K., Bezprozvannaya S., Chang S., Olson E.N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy // J Clin Investig. 2006. Vol. 116. N 7. P. 1853–1864. doi: 10.1172/JCI27438.
  10. Humphrey J.D., Dufresne E.R., Schwartz M.A. Mechanotransduction and extracellular matrix homeostasis // Nat Rev Mol Cell Biol. 2014. Vol. 15. N 12. P. 802–812. doi: 10.1038/nrm3896.
  11. Salica J.P., Guerrieri D., Maffia P., Croxatto J.O., Chuluyan H.E., Gallo J.E. Transglutaminase binding fusion protein linked to SLPI reduced corneal inflammation and neovascularization // BMC Ophthalmol. 2015. Vol. 15. P. 12. doi: 10.1186/1471-2415-15-12.
  12. Chun Q., ZhiYong W., Fei S., XiQiao W. Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression // Int Wound J. 2016. Vol. 13. N. 2. P. 257–262. doi: 10.1111/iwj.12283.
  13. Wang X., Abraham S., McKenzie J.A.G., Jeffs N., Swire M., Tripathi V.B., et al. LRG1 promotes angiogenesis by modulating endothelial TGF-beta signaling // Nature. 2013. Vol. 499. N 7458. P. 306–311. doi: 10.1038/nature12345.
  14. Bengtsson E., Lindblom K., Tillgren V., Aspberg A. The leucine-rich repeat protein PRELP binds fibroblast cell-surface proteoglycans and enhances focal adhesion formation // Biochemical J. 2016. Vol. 473. N 9. P. 1153–1164. doi: 10.1042/BCJ20160095.
  15. Gao Y., Zhou J., Xie Z., Wang J., Ho C.K., Zhang Y., Li Q. Mechanical strain promotes skin fibrosis through LRG-1 induction mediated by ELK1 and ERK signaling // Commun Biol. 2019. Vol. 2. N 359. doi: 10.1038/s42003-019-0600-6.
  16. Harrell M.I., Iritani B.M., Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis // Am J Pathol. 2007. Vol. 170. N 2. P. 774–786.
  17. Abouelkheir G.R., Upchurch B.D., Rutkowski J.M. Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation’s fire? // Exp Biol Med (Maywood). 2017. Vol. 242. N 8. P. 884–895. doi: 10.1177/1535370217697385.
  18. Sund B. New developments in wound care. London: PJB Publications; 2000.
  19. Van der Auwera I., Cao Y., Tille J.C., Pepper M.S., Jackson D.G., Fox S.B., et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours // Br J Cancer. 2006. Vol. 95. N 12. 1611–1625.
  20. Abu-Nab Z., Grunfeld E.A. Satisfaction with outcome and attitudes towards scarring among women undergoing breast reconstructive surgery // Patient Educ Couns. 2007. Vol. 66. N 2. P. 243–249.
  21. Bakker A., Maertens K.J., Van Son M.J., Van Loey N.E. Psychological consequences of pediatric burns from a child and family perspective: a review of the empirical literature // Clin Psychol Rev. 2013. Vol. 33. N 3. P. 361–371. doi: 10.1016/j.cpr.2012.12.006.
  22. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration // Nature. 2008. Vol. 453. P. 314–321. doi: 10.1038/nature07039.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 86496 от 11.12.2023 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ЭЛ № ФС 77 - 80673 от 23.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies